Bibliographic information

GuidelineMedical eligibility criteria for contraceptive use, 6th ed.
Year of Publication2025
Issuing InstitutionWorld Health Organization

Recommendation

Maintained

Women living with asymptomatic or mild HIV clinical disease (WHO stage 1 or 2) can use the following hormonal contraceptive methods without restriction: combined oral contraceptive (pill) (COCs), combined injectable contraceptives (CICs), combined contraceptive patches and rings, progestogen-only pill(POPs), progestogen-only injectable(POIs) (DMPA and NET-EN), and levonorgestrel (LNG) and etonogestrel(ETG) implants

Notes and Remarks

Because there may be drug interactions between hormonal contraceptives and antiretroviral therapy (ART), refer to the last section of this (the guideline) table, on drug interactions

Also Featured In

This recommendation also appears in the following guidelines:

Originally Developed
Guideline

Medical eligibility criteria for contraceptive use

Year2015
InstitutionWorld Health Organization